Table II.
Properties | Crizotinib | Ceritinib | Brigatinib | Alectinib | Lorlatinib | Entrectinib |
---|---|---|---|---|---|---|
Molecular formula (mg/mole) | 450.34 | 558.14 | 584.10 | 482.62 | 406.41 | 560.64 |
Molecular weight | C21H22Cl2FN5O | C28H36ClN5O3S | C29H39ClN7O2P | C30H34N4O2 | C21H19FN6O2 | C31H34F2N6O2 |
Octanol/water | 1.65 (pH 7.4) | 5.23 | 5.17 | NA | 2.45 (pH 9) | NA |
Water solubility | 0.00611 mg/ml | 0.00222 mg/ml | 0.022 mg/ml | NA | 32.38–0.17 (pH 2.55–8.02) | NA |
pKa | 9.4 and 5.6 | 9.7 and 4.1 | NA | 7.05 (base) | 4.9 | NA |
ALK-TKIs, anaplastic lymphoma kinase tyrosine kinase inhibitors; NA, not available; pKa, symbol for acid dissociation constant at logarithmic scale.